CompletedNot Applicable

Comparative Study Between Oxytocin Infusion Before and After Placental Delivery on Blood Loss During and After Cesarean Delivery .

Egypt64 participantsStarted 2023-08-30

Plain-language summary

Participants were randomized using computer-generated random numbers into 2 groups. Group I included 32 women who received oxytocin infusion before placental delivery just after cord clamping and group II included 32 women who received oxytocin infusion after placental delivery. In both groups 10 IU of oxytocin (Syntocinon, Novartis, Basel, Switzerland) were diluted in 500 mL of normal saline and administered through intravenous infusion over 30 minutes.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 - 40 years * singleton full term pregnancy. * Candidate for elective cesarean delivery under spinal anaesthesia Exclusion Criteria: * women at high risk for intraoperative bleeding as those with placenta previa or other placental abnormalities * women with bleeding or coagulation disorders. * Medical disorder associating pregnancy as preeclampsia or diabetes * Allergy or contraindications to oxytocin * Fetal macrosomia, or congenital anomalies * Polyhydramnios * Uterine abnormalities as fibroids * Women with intraoperative complications as vascular or visceral injuries

What they're measuring

Intraoperative blood loss

Timeframe: during cesarean delivery

Trial details

NCT IDNCT06889155

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-27

View on ClinicalTrials.gov More Intraoperative Blood Loss trials